TWD 62.7
(2.96%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.21 Billion TWD | 3.46% |
2022 | 1.17 Billion TWD | -7.18% |
2021 | 1.26 Billion TWD | 14.1% |
2020 | 1.1 Billion TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 1.39 Billion TWD | 0.77% |
2024 Q1 | 1.38 Billion TWD | 14.37% |
2023 Q4 | 1.21 Billion TWD | 3.56% |
2023 FY | 1.21 Billion TWD | 3.46% |
2023 Q3 | 1.17 Billion TWD | 2.36% |
2023 Q2 | 1.14 Billion TWD | 1.72% |
2023 Q1 | 1.12 Billion TWD | 0.0% |
2022 FY | 1.17 Billion TWD | -7.18% |
2022 Q4 | - TWD | 0.0% |
2021 FY | 1.26 Billion TWD | 14.1% |
2020 FY | 1.1 Billion TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Allied Biotech Corporation | 2.07 Billion TWD | 41.614% |
GeneFerm Biotechnology Co., Ltd. | 1.17 Billion TWD | -3.268% |
TTY Biopharm Company Limited | 9.87 Billion TWD | 87.708% |
Synmosa Biopharma Corporation | 11.72 Billion TWD | 89.651% |
Orient EuroPharma Co., Ltd. | 10.81 Billion TWD | 88.774% |
Center Laboratories, Inc. | 27 Billion TWD | 95.505% |
Tien Liang BioTech Co., Ltd. | 654.03 Million TWD | -85.584% |
Orient Pharma Co., Ltd. | 2.56 Billion TWD | 52.636% |
InnoPharmax Inc. | 524.19 Million TWD | -131.552% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 1.99 Billion TWD | 39.096% |
Excelsior Biopharma Inc. | 1.57 Billion TWD | 23.048% |
DV Biomed Co., Ltd. | 1.81 Billion TWD | 33.038% |
Foresee Pharmaceuticals Co., Ltd. | 1.86 Billion TWD | 34.793% |
Handa Pharmaceuticals, Inc. | 3.03 Billion TWD | 60.036% |
UniPharma Co., Ltd. | 350.07 Million TWD | -246.722% |
Anxo Pharmaceutical Co., Ltd. | 2.21 Billion TWD | 45.29% |
Alar Pharmaceuticals Inc. | 973.2 Million TWD | -24.72% |
Winston Medical Supply Co., Ltd. | 801.77 Million TWD | -51.387% |
Mercury Biopharmaceutical Corporation | 438.07 Million TWD | -177.072% |
Bioray Biotech Co., Ltd | 542.64 Million TWD | -123.678% |
TSH Biopharm Corporation Limited | 1.39 Billion TWD | 13.292% |